10x Genomics, Inc. (TXG) stock
TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30106% above fair value
$56.30+1.31 (+2.38%)
Close on Nov 17, 2026Market cap $7.34BP/E –Yield –
10x Genomics total assets
Total assets on the balance sheet at the end of each period.
10x Genomics's total assets was $1.06B at Sep 30, 2026. For fiscal 2025 it was $1.04B, up 13.4% from the year before. The highest annual figure on record is $1.04B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.04B | +13.4% |
| FY2024 | Dec 31, 2024 | $918.64M | -4.8% |
| FY2023 | Dec 31, 2023 | $965.14M | -6.2% |
| FY2022 | Dec 31, 2022 | $1.03B | +1.0% |
| FY2021 | Dec 31, 2021 | $1.02B | +9.6% |
| FY2020 | Dec 31, 2020 | $929.34M | +53.4% |
| FY2019 | Dec 31, 2019 | $605.92M | +387.4% |
| FY2018 | Dec 31, 2018 | $124.31M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.06B | +3.5% |
| Q2 FY2026 | Jun 30, 2026 | $1.03B | +5.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.02B | +12.4% |
| Q4 FY2025 | Dec 31, 2025 | $1.04B | +13.4% |
| Q3 FY2025 | Sep 30, 2025 | $1.03B | +9.6% |
| Q2 FY2025 | Jun 30, 2025 | $979.97M | +5.4% |
| Q1 FY2025 | Mar 31, 2025 | $903.39M | -2.1% |
| Q4 FY2024 | Dec 31, 2024 | $918.64M | -4.8% |
| Q3 FY2024 | Sep 30, 2024 | $937.79M | -1.1% |
| Q2 FY2024 | Jun 30, 2024 | $929.67M | -6.1% |
| Q1 FY2024 | Mar 31, 2024 | $922.91M | -9.0% |
| Q4 FY2023 | Dec 31, 2023 | $965.14M | -6.2% |
| Q3 FY2023 | Sep 30, 2023 | $948.54M | -4.8% |
| Q2 FY2023 | Jun 30, 2023 | $989.64M | -1.2% |
| Q1 FY2023 | Mar 31, 2023 | $1.01B | +1.1% |
| Q4 FY2022 | Dec 31, 2022 | $1.03B | +1.0% |
| Q3 FY2022 | Sep 30, 2022 | $996.21M | +0.6% |
| Q2 FY2022 | Jun 30, 2022 | $1.00B | +2.5% |
| Q1 FY2022 | Mar 31, 2022 | $1.00B | +5.2% |
| Q4 FY2021 | Dec 31, 2021 | $1.02B | +9.6% |
| Q3 FY2021 | Sep 30, 2021 | $990.57M | -5.0% |
| Q2 FY2021 | Jun 30, 2021 | $977.58M | +67.7% |
| Q1 FY2021 | Mar 31, 2021 | $954.03M | +56.3% |
| Q4 FY2020 | Dec 31, 2020 | $929.34M | +53.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.04B | +82.0% |
| Q2 FY2020 | Jun 30, 2020 | $582.80M | +368.8% |
| Q1 FY2020 | Mar 31, 2020 | $610.38M | – |
| Q4 FY2019 | Dec 31, 2019 | $605.92M | – |
| Q3 FY2019 | Sep 30, 2019 | $572.82M | – |
| Q4 FY2018 | Dec 31, 2018 | $124.31M | – |
See a number that looks wrong?